Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT34-CLI: CD34+ Cells for Critical Limb Ischemia
NCT00616980Phase 2Completed
- Start
- Dec 2007
- Primary completion
- Apr 2010
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous CD34-positive cells in critical limb ischemia (CLI). Started Dec 2007; status: completed.
02
Drugs
autologous CD34-positive cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00616980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616980.